CLEAR Outcomes trial post-hoc
Bempedoic acid reduces Major Adverse Cardiovascular Events & Major Adverse Limb Events
In 1624 with baseline PAD, 282 MALEs in 41 mo f/up
Absolute risk reduction 2.5% 8.3%➡️5.8%
♂️♀️?🤓
#CircAHA 2026
www.ahajournals.org/doi/10.1161/...
CLEAR Outcomes trial post-hoc
Bempedoic acid reduces Major Adverse Cardiovascular Events & Major Adverse Limb Events
In 1624 with baseline PAD, 282 MALEs in 41 mo f/up
Absolute risk reduction 2.5% 8.3%➡️5.8%
♂️♀️?🤓
#CircAHA 2026
www.ahajournals.org/doi/10.1161/...
Collab with Lulu Ren (former @mcipucd.bsky.social) & Joe Wu's Lab
@ucdavis.bsky.social
www.ahajournals.org/doi/10.1161/...
Collab with Lulu Ren (former @mcipucd.bsky.social) & Joe Wu's Lab
@ucdavis.bsky.social
www.ahajournals.org/doi/10.1161/...
Endothelial Cell Cycle
#ArterioVenousMalformation
#HereditaryHemorrhagicTelangiectasia
Evidence from
👉Fucci2🐭 (fluorescent cell cycle reporter) Retina +BMP9/10 blocking Ab
+Palbociclib CDK4/6i
👉🐭EC ALK1 KO👁️🧠
+Palbociclib
👉👤HHT2 Skin biopsy
#CircAHA 2024
www.ahajournals.org/doi/full/10....
Endothelial Cell Cycle
#ArterioVenousMalformation
#HereditaryHemorrhagicTelangiectasia
Evidence from
👉Fucci2🐭 (fluorescent cell cycle reporter) Retina +BMP9/10 blocking Ab
+Palbociclib CDK4/6i
👉🐭EC ALK1 KO👁️🧠
+Palbociclib
👉👤HHT2 Skin biopsy
#CircAHA 2024
www.ahajournals.org/doi/full/10....
J-SHC >500k, 4 y f/up, 84 events -AD mortality
UK Biobank >500k, 9 y f/up, 182 events -AD incidence
+Meta-analysis 6 prev studies
#AortaEd
#CircAHA 2021
www.ahajournals.org/doi/10.1161/...
J-SHC >500k, 4 y f/up, 84 events -AD mortality
UK Biobank >500k, 9 y f/up, 182 events -AD incidence
+Meta-analysis 6 prev studies
#AortaEd
#CircAHA 2021
www.ahajournals.org/doi/10.1161/...
Learn more about seamlessly transferring your manuscript between @NEJM and @CircAHA #ACC26
https://www.ahajournals.org/circ/nejm-circulation-collaboration
Learn more about seamlessly transferring your manuscript between @NEJM and @CircAHA #ACC26
https://www.ahajournals.org/circ/nejm-circulation-collaboration
Learn more about seamlessly transferring your manuscript between @NEJM and @CircAHA #ACC26
https://www.ahajournals.org/circ/nejm-circulation-collaboration
Learn more about seamlessly transferring your manuscript between @NEJM and @CircAHA #ACC26
https://www.ahajournals.org/circ/nejm-circulation-collaboration
https://ahajrnls.org/41aarWz
https://ahajrnls.org/41aarWz
Learn more about seamlessly transferring your manuscript between @NEJM and @CircAHA #ACC26
https://www.ahajournals.org/circ/nejm-circulation-collaboration
Learn more about seamlessly transferring your manuscript between @NEJM and @CircAHA #ACC26
https://www.ahajournals.org/circ/nejm-circulation-collaboration
Learn about new and upcoming journal initiatives, gain insight into journal processes, and don't forget to bring your questions for the editors!
Register today: https://ahajrnls.org/3Pz8wbN
Learn about new and upcoming journal initiatives, gain insight into journal processes, and don't forget to bring your questions for the editors!
Register today: https://ahajrnls.org/3Pz8wbN
https://ahajrnls.org/41aarWz
https://ahajrnls.org/41aarWz
Learn more about seamlessly transferring your manuscript between @NEJM and @CircAHA #ACC26
https://www.ahajournals.org/circ/nejm-circulation-collaboration
Learn more about seamlessly transferring your manuscript between @NEJM and @CircAHA #ACC26
https://www.ahajournals.org/circ/nejm-circulation-collaboration
Second heart field▶️Isl1-Dre::Myh11-RSR-CreER
Cardiac neural crest▶️Wnt1-Dre
Somite▶️Meox1-DreER
Mesothelial/Visceral▶️Upk3b-Dre
Bin Zhou lab @CircAHA 2025
www.ahajournals.org/doi/10.1161/...
Second heart field▶️Isl1-Dre::Myh11-RSR-CreER
Cardiac neural crest▶️Wnt1-Dre
Somite▶️Meox1-DreER
Mesothelial/Visceral▶️Upk3b-Dre
Bin Zhou lab @CircAHA 2025
www.ahajournals.org/doi/10.1161/...
#SmoothMuscleCell Progerin transgene drives #EndMT #Atherosclerosis🐭
⏫Aortic Endothelial Cell permeability
⏫Lesional EC infiltr▶️ColIV- & TGFβ1-rich plaque😮
Paracrine of progeroid aortic SMC?😆
#CircAHA 2024
www.ahajournals.org/doi/10.1161/...
#SmoothMuscleCell Progerin transgene drives #EndMT #Atherosclerosis🐭
⏫Aortic Endothelial Cell permeability
⏫Lesional EC infiltr▶️ColIV- & TGFβ1-rich plaque😮
Paracrine of progeroid aortic SMC?😆
#CircAHA 2024
www.ahajournals.org/doi/10.1161/...
EHJ and Circulation: Advances in 2025
Featuring Dr. Joseph A. Hill, Dr. Maryjane Farr, and other @CircAHA editors
Saturday 11/8 @ 1:30-2:45pm
Room 210
Add to your schedule: https://ahajrnls.org/43ihSN5
EHJ and Circulation: Advances in 2025
Featuring Dr. Joseph A. Hill, Dr. Maryjane Farr, and other @CircAHA editors
Saturday 11/8 @ 1:30-2:45pm
Room 210
Add to your schedule: https://ahajrnls.org/43ihSN5
EHJ and Circulation: Advances in 2025
Featuring Dr. Joseph A. Hill, Dr. Maryjane Farr, and other @CircAHA editors
Saturday 11/8 @ 1:30-2:45pm
Room 210
Add to your schedule: https://ahajrnls.org/43ihSN5
EHJ and Circulation: Advances in 2025
Featuring Dr. Joseph A. Hill, Dr. Maryjane Farr, and other @CircAHA editors
Saturday 11/8 @ 1:30-2:45pm
Room 210
Add to your schedule: https://ahajrnls.org/43ihSN5
Learn more about seamlessly transferring your manuscript between @NEJM and @CircAHA #AHA25
https://www.ahajournals.org/circ/nejm-circulation-collaboration
Learn more about seamlessly transferring your manuscript between @NEJM and @CircAHA #AHA25
https://www.ahajournals.org/circ/nejm-circulation-collaboration
Circulating Global Health Knowledge: Key Findings from AHA Journals
Featuring Editors from #CircAHA, #CircImaging, and more
Fri 11/7 @ 2-3:15pm
Room 243
Add to your schedule: https://ahajrnls.org/4ouw4Lw
Circulating Global Health Knowledge: Key Findings from AHA Journals
Featuring Editors from #CircAHA, #CircImaging, and more
Fri 11/7 @ 2-3:15pm
Room 243
Add to your schedule: https://ahajrnls.org/4ouw4Lw
🫀 A growing group of patients with subclinical atherosclerosis falls in between traditional "primary" and "secondary" prevention. I've heard of "prevention 1.5" or "plaque-informed prevention." How about the following classification system?👇
🫀 A growing group of patients with subclinical atherosclerosis falls in between traditional "primary" and "secondary" prevention. I've heard of "prevention 1.5" or "plaque-informed prevention." How about the following classification system?👇
Learn more about seamlessly transferring your manuscript between @nejm.org and #CircAHA
https://www.ahajournals.org/circ/nejm-circulation-collaboration
#TCT2025
Learn more about seamlessly transferring your manuscript between @nejm.org and #CircAHA
https://www.ahajournals.org/circ/nejm-circulation-collaboration
#TCT2025
Authors now have the option to select a seamless transfer of their manuscript between NEJM and Circulation. #TCT2025
Learn more: https://ahajrnls.org/4oGZ4Q2
Authors now have the option to select a seamless transfer of their manuscript between NEJM and Circulation. #TCT2025
Learn more: https://ahajrnls.org/4oGZ4Q2
Learn more about seamlessly transferring your manuscript between @nejm.org and #CircAHA
https://www.ahajournals.org/circ/nejm-circulation-collaboration
#TCT2025
Learn more about seamlessly transferring your manuscript between @nejm.org and #CircAHA
https://www.ahajournals.org/circ/nejm-circulation-collaboration
#TCT2025
#SmoothMuscleCell
1⃣H2A.Z
⬇️in #Atherosclerosis
⏫SMC contractile gene
#CircAHA 2018
www.ahajournals.org/doi/10.1161/...
#BMCGenom 2025
bmcgenomics.biomedcentral.com/articles/10....
2⃣H3.3B
⬆️in #AorticDissection
⏫SMC synthetic genes
#Genomics 2023
www.sciencedirect.com/science/arti...
#SmoothMuscleCell
1⃣H2A.Z
⬇️in #Atherosclerosis
⏫SMC contractile gene
#CircAHA 2018
www.ahajournals.org/doi/10.1161/...
#BMCGenom 2025
bmcgenomics.biomedcentral.com/articles/10....
2⃣H3.3B
⬆️in #AorticDissection
⏫SMC synthetic genes
#Genomics 2023
www.sciencedirect.com/science/arti...
TET2 #DNADemethylase #MethylcytosineDioxygenase, an epigenomic defender of #SmoothMuscleCell contractile phenotype
⏬Interferon IFNγ in SMC
Ascorbic acid
⏫TET2 activity
⏬🐭aortic #GraftArteriopathy
#CircAHA 2021 @ahajournals.bsky.social
www.ahajournals.org/doi/10.1161/...
TET2 #DNADemethylase #MethylcytosineDioxygenase, an epigenomic defender of #SmoothMuscleCell contractile phenotype
⏬Interferon IFNγ in SMC
Ascorbic acid
⏫TET2 activity
⏬🐭aortic #GraftArteriopathy
#CircAHA 2021 @ahajournals.bsky.social
www.ahajournals.org/doi/10.1161/...
🚨 HCM isn’t just driven by rare Mendelian mutations. This study highlights the role of intermediate-effect variants (IEVs)—variants with moderate effect & low penetrance—in shaping disease expression. #HCM #SoMeEditor
tinyurl.com/HCM-IEVs
🚨 HCM isn’t just driven by rare Mendelian mutations. This study highlights the role of intermediate-effect variants (IEVs)—variants with moderate effect & low penetrance—in shaping disease expression. #HCM #SoMeEditor
tinyurl.com/HCM-IEVs
Circulation: The Full Spectrum
Sunday, 8/31 @ 17:30 - 18:30
Add it to your program today!: https://ahajrnls.org/47TBD0p
Circulation: The Full Spectrum
Sunday, 8/31 @ 17:30 - 18:30
Add it to your program today!: https://ahajrnls.org/47TBD0p